Lv1
30 积分 2025-05-30 加入
Rechallenge With BRAF and anti-EGFR Inhibitors in Patients With Metastatic Colorectal Cancer Harboring BRAF Mutation Who Progressed on Cetuximab and Encorafenib With or Without Binimetinib: A Case Series
1天前
待确认
BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanoma
1天前
已完结
Pancreatic Cancer
5天前
已完结
Pancreatic cancer
6天前
已完结
Metastatic pancreatic cancer and the liver
6天前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
19天前
已完结
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
19天前
已完结
Golidocitinib, a selective JAK1 tyrosine-kinase inhibitor, in patients with refractory or relapsed peripheral T-cell lymphoma (JACKPOT8 Part B): a single-arm, multinational, phase 2 study
21天前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
21天前
已完结
Safety and outcomes of intensity modulated proton therapy in patients with non small cell lung cancer with interstitial lung disease
1个月前
已完结
皖公网安备34019202002308
